Shares of Bio Medica Laboratories are set to debut on the NSE SME platform on Friday amid weak grey market sentiment, with the IPO currently commanding a negative premium in the unofficial market. The company’s shares were trading at a discount in the grey market ahead of listing, indicating the possibility of a subdued market debut.
The Rs 52 crore IPO had opened for subscription between May 21 and May 25, while the allotment was finalised on May 26. The issue was a combination of a fresh issue of 33.95 lakh shares worth around Rs 47.19 crore and an offer for sale of 3.77 lakh shares aggregating to Rs 5.24 crore.